worldwide offices | contact | help | sitemap

 
 

 

 

 

Novartis Diagnostics Products

Products

Approvals

Definitions

"Approved"
The registration of the product has been approved by the appropriate authority in a given country.

"Cleared"
FDA has agreed that the product is substantially equivalent to a device already legally marketed in the U.S. (per section 510(k)); therefore the product is available for promotion and sale in the U.S. This applies to the U.S. only.

"Marketable"
Product can be promoted and is available for sale; specific to countries where no formal regulatory approval process exists for given product.

 

 

Products

1. PROCLEIX® Assays

 

2. PROCLEIX® Instruments

 

3. PROCLEIX® Software

 

4. RIBA

 

Back to top

About Novartis Vaccines

About Novartis Vaccines

Novartis Vaccines is a leader in providing products to fight more than 20 vaccine-preventable viral and bacterial diseases. Novartis Vaccines is the division researching novel treatments.

Brochures

Brochures

Novartis Diagnostics is transforming the landscape of disease prevention, diagnosis, monitoring and treatment.